BioCatalystWatch
AMRXWorkspace / AMRX / OverviewCompany library
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (AMRX)

Website

Featured programme · Omalizumab biosimilar

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Epinephrine injection presentations

Alpha-adrenergic receptors × Beta-adrenergic receptors

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Omalizumab biosimilar

Free IgE

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Omalizumab biosimilar

Free IgE

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

Epinephrine injection presentations

Alpha-adrenergic receptors × Beta-adrenergic receptors

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

Approved / commercial

Albuterol sulfate

Approved

PreINDP1P2P3FilingApproved
BONCRESA

Approved

PreINDP1P2P3FilingApproved
CREXONT

Approved

PreINDP1P2P3FilingApproved
Everolimus

Approved

PreINDP1P2P3FilingApproved
Iohexol

Approved

PreINDP1P2P3FilingApproved

History / paused

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AMRX PR & News

PR & News

AMRX SEC archive